“…Although clinical studies show a clear correlation of gestational (Entringer, Buss, & Wadhwa, 2010;Goldstein et al, 2016) and childhood stress (Agardh, Allebeck, Hallqvist, Moradi, & Sidorchuk, 2011;Danese & Tan, 2014;Thomas, Hypponen, & Power, 2008) with metabolic risk, whether the effects of ELS can be accurately replicated in animal models remains unknown. In agreement with our results, several reports have shown that PNS causes fasting hyperglycemia in adults (Detka et al, 2014;Lesage et al, 2004;Paternain et al, 2013), without further affecting glucose tolerance (Panetta et al, 2017). However, only a few reports have addressed the effect of MS180 on metabolic risk (Ruiz et al, 2018;Solas et al, 2010;Vargas et al, 2016).…”